Obesity Drugs Are Pharma's Hot New Trend - Bloomberg
Novo Nordisk CEO on Acquisition Targets in Biotech
Novo Nordisk forgylder topchef efter rekordresultat
Lars Fruergaard Jørgensen
Novo Nordisk, World Leader in Diabetes Drugs, Is Set to Rally | Barron's
Lars Rebien Sørensen to step down as head of Novo Nordisk - The Copenhagen Post – The Copenhagen Post
All the way to the top
Novo-topchef hentede løn på 58 mio. sidste år
Novo Nordisk CEO on Acquisition Targets in Biotech
Lars Jørgensen Net Worth, Biography, and Insider Trading
Årets Leder 2020, Lars Fruergaard Jørgensen, CEO i Novo Nordisk - YouTube
Det tjener cheferne: Årsløn 57 millioner - Avisen.dk
Novo Nordisk CEO on his legacy: What I spend most of my time on — MedWatch
Novo CEO's salary takes quantum leap - earns more than DKK 40 million — MedWatch
UPDATED: Novo Nordisk chief Lars Rebien Sorensen to step down early as pricing pressures mount | Fierce Pharma
Lars Fruergaard Jorgensen, Novo Nordisk A/S: Profile and Biography - Bloomberg Markets
Novo Considers Gene-Therapy Deals Amid Pressure on Drug Prices - Bloomberg
Watch Novo Nordisk CEO Lars Fruergaard Jorgensen on Coronavirus Outbreak, Earnings, 2020 Outlook - Bloomberg
Artikler om Lars Fruergaard Jørgensen | Lederstof
Lars Rebien Sørensen - Wikipedia
Lars Fruergaard Jorgensen a model for 'Novo Nordisk Way' | Financial Times
